Toinv - One way to narrow down your list of potentail partner candidates is to look at the ones that sell SGLT2's. On one of the posters presented in the last 9 months it said the number of patients that were on those drugs. From memory, which isn't as good as it used to be, there were some 286ish such patients. Of that group I believe over 200 were taking Jardiance but I can not find where I read or heard that. 

A pharma with a combination drug that could reduce CHF by something over 50% in diabetic patients with CVD could end up making a lot of money. I think there are only 5 or 6 pharmas that have SGLT2's in their product lines.

tada